======= WDR5 ======= == Gene Information == * **Official Symbol**: WDR5 * **Official Name**: WD repeat domain 5 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=11091|11091]] * **UniProt**: [[https://www.uniprot.org/uniprot/P61964|P61964]] * **Interactions**: [[https://thebiogrid.org/search.php?search=WDR5&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20WDR5|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609012|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. This protein contains 7 WD repeats. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Contributes to histone modification. May position the N- terminus of histone H3 for efficient trimethylation at 'Lys-4'. As part of the MLL1/MLL complex it is involved in methylation and dimethylation at 'Lys-4' of histone H3. H3 'Lys-4' methylation represents a specific tag for epigenetic transcriptional activation. As part of the NSL complex it may be involved in acetylation of nucleosomal histone H4 on several lysine residues. May regulate osteoblasts differentiation. {ECO:0000269|PubMed:16600877, ECO:0000269|PubMed:16829960, ECO:0000269|PubMed:19103755, ECO:0000269|PubMed:19556245, ECO:0000269|PubMed:20018852}. |eIF2A| |WD40| |positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter| |regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter| |histone acetyltransferase activity (H4-K5 specific)| |histone acetyltransferase activity (H4-K16 specific)| |histone acetyltransferase activity (H4-K8 specific)| |regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter| |Set1C/COMPASS complex| |positive regulation of gluconeogenesis| |MLL3/4 complex| |histone H4-K8 acetylation| |histone methyltransferase activity (H3-K4 specific)| |histone H4-K5 acetylation| |Ada2/Gcn5/Ada3 transcription activator complex| |histone H4-K16 acetylation| |histone acetyltransferase complex| |MLL1 complex| |histone H3-K4 methylation| |positive regulation of glucose metabolic process| |histone methyltransferase complex| |regulation of gluconeogenesis| |histone H3 acetylation| |regulation of megakaryocyte differentiation| |histone H4 acetylation| |positive regulation of cellular carbohydrate metabolic process| |methylated histone binding| |histone lysine methylation| |positive regulation of carbohydrate metabolic process| |peptidyl-lysine methylation| |histone methylation| |regulation of carbohydrate biosynthetic process| |regulation of glucose metabolic process| |histone acetylation| |internal peptidyl-lysine acetylation| |peptidyl-lysine acetylation| |internal protein amino acid acetylation| |histone binding| |protein methylation| |protein alkylation| |positive regulation of small molecule metabolic process| |regulation of cellular carbohydrate metabolic process| |protein acetylation| |protein acylation| |regulation of carbohydrate metabolic process| |regulation of myeloid cell differentiation| |macromolecule methylation| |methylation| |peptidyl-lysine modification| |post-translational protein modification| |histone modification| |covalent chromatin modification| |regulation of small molecule metabolic process| |regulation of hemopoiesis| |skeletal system development| |neuron projection development| |chromatin organization| |neuron development| |peptidyl-amino acid modification| |neuron differentiation| |chromosome organization| |plasma membrane bounded cell projection organization| |cell projection organization| |positive regulation of transcription by RNA polymerase II| |generation of neurons| |positive regulation of transcription, DNA-templated| |neurogenesis| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |cell development| |regulation of immune system process| |positive regulation of RNA metabolic process| |regulation of cell differentiation| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp147|Resveratrol 16μM R03 exp147]]|-1.8| |[[:results:exp526|Sulforaphane 9μM R08 exp526 no dilution day6]]|1.7| |[[:results:exp198|Etoposide 0.1μM R05 exp198]]|1.72| |[[:results:exp210|LB-100 2μM R05 exp210]]|1.74| |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|1.82| |[[:results:exp16|DABN 2μM R00 exp16]]|1.83| |[[:results:exp240|Pyridostatin 4μM R05 exp240]]|1.88| |[[:results:exp288|HMS-I2 10μM R06 exp288]]|1.9| |[[:results:exp135|MS023 7μM R03 exp135]]|1.98| |[[:results:exp1|5-Fluorouracil 2μM R00 exp1]]|1.99| |[[:results:exp520|Rucaparib 6.5μM R08 exp520]]|1.99| |[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|2.04| |[[:results:exp241|QNZ 0.01μM R05 exp241]]|2.15| |[[:results:exp503|Mitomycin-C 0.06μM R08 exp503]]|2.2| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|2.76| |[[:results:exp242|Radicicol 0.16μM R05 exp242]]|2.8| |[[:results:exp2|5-Fluorouracil 20μM R00 exp2]]|3.4| ^Gene^Correlation^ |[[:human genes:z:zzz3|ZZZ3]]|0.47| |[[:human genes:y:yeats2|YEATS2]]|0.415| |[[:human genes:t:tada2a|TADA2A]]|0.407| Global Fraction of Cell Lines Where Essential: 696/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|27/28| |blood|28/28| |bone|25/25| |breast|32/33| |central nervous system|56/56| |cervix|4/4| |colorectal|17/17| |esophagus|12/13| |fibroblast|1/1| |gastric|15/15| |kidney|20/21| |liver|19/20| |lung|69/75| |lymphocyte|14/14| |ovary|26/26| |pancreas|23/24| |peripheral nervous system|16/16| |plasma cell|13/15| |prostate|1/1| |skin|19/24| |soft tissue|6/7| |thyroid|2/2| |upper aerodigestive|21/22| |urinary tract|27/29| |uterus|5/5| == Essentiality in NALM6 == * **Essentiality Rank**: 135 * **Expression level (log2 read counts)**: 6.65 {{:chemogenomics:nalm6 dist.png?nolink |}}